相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
PDGFRa / CD140a抗体
抗体类型: Rabbit Monoclonal Antibody ( Rabbit mAb Service Platform )
克隆号 : 65
抗体宿主 : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : This antibody was obtained from a rabbit immunized with purified, human cell-derived, recombinant human PDGFRa / CD140a (rhPDGFRa ; Catalog#10556-H08H ; NP_006197.1 ; Met 1- Glu 524)
PDGFRa / CD140a抗体背景综述
PDGFRα, also known as CD140a, together with the structurally homolog protein PDGFRβ (CD140b), are cell surface receptors for members of the platelet-derived growth factor family. They are members of the class III subfamily of receptor tyrosine kinase (RTKs) with the similar structure characteristics of five immunoglobulin -like domains in their extracellular region and a split kinase domain in their intracellular region. PDGFRα is expressed in oligodendrocyte progenitor cells and mesothelial cell, and binds all three ligand isoforms PDGF-AA, PDGF-BB and PDGF-AB with high affinity, whereas PDGFRβ dose not bind PDGF-AA. PDGF binding induces the receptor homo- and hetero-dimerization as well as activation of the receptor, and subsequently activates c-Src tyrosine kinase which relays signals to PI 3 kinase and MAPK cascades. PDGFRα thus plays an essential role in regulating proliferation, chemotaxis and migration of mesangial cells. Recent studies have indicated that PDGFRα acts as a critical mediator of signaling in testis organogenesis and Leydig cell differentiation, and in addition, particularly important for kidney development.
PDGFRa / CD140a抗体相关产品如下:xy-10542R Topoisomerase I拓普西异构酶Ⅰ抗体
xy-13712R TIN-Ag肾小管间质肾炎抗原抗体
xy-13622R TMEM176A跨膜蛋白176A抗体
xy-13623R TMEM176A跨膜蛋白176A抗体
xy-10266R TBX3转录因子Tbx3抗体
xy-10505R tinagl1tinagl1抗体
xy-8534R TRPV5辣椒素受体5抗体
xy-0149R TRA1 variant肿瘤排斥抗原gp96 1 变异体抗体
xy-2535R TFPI/LACI组织因子途径抑制剂抗体
xy-6744R TRIM47星形细胞瘤高表达蛋白抗体(环指蛋白100)
xy-12863R TUBB5微管蛋白β5抗体
xy-3580R TRIM24转录中介因子Tif1α抗体
xy-3581R KAP1转录中介因子Tif1β抗体
xy-3423R Phospho-TIF1 beta(Ser824)磷酸化转录中介因子Tif1β抗体
xy-3592R Tyk2非受体酪氨酸蛋白激酶2抗体
xy-3582R TIF1 gamma转录中介因子Tif1γ抗体
xy-3583R TLK1调节染色体组装激酶1抗体
xy-3578R TCTP翻译控制肿瘤蛋白抗体
xy-6745R TSP50肿瘤/睾丸抗原20抗体
xy-6739R TIMM17A线粒体内膜转位酶抗体
xy-9409R RNF9环指蛋白9抗体
xy-4600R TIMP-1(CT)金属蛋白酶组织抑制因子-1抗体(C端)
xy-13612R Tex19A睾丸表达蛋白19A抗体
xy-2963R TASK 3酸敏感性钾离子通道蛋白抗体
xy-2964R TSLP胸腺基质淋巴细胞生成素-1抗体
xy-2977R TAGL2细胞骨架相关蛋白2抗体
xy-6635R TCEB3转录延伸因子3抗体
xy-6637R TP53I8肿瘤蛋白p53诱导蛋白8
xy-6801R TCERG1转录延伸调节蛋白1抗体
xy-11491R Torsin B扭转蛋白B抗体
xy-11510R TTC8巴尔得-别德尔综合征相关蛋白8抗体
xy-11615R TAS2R7味觉受体蛋白家族2亚基7抗体
xy-11617R T2R50味觉受体蛋白家族2亚基50抗体
xy-11606R TWSG1扭转原肠胚形成同源蛋白1抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验(杨希峰),Yang CY(杨春瑛) et al. Generation and characterization of monoclonal antibody against HIT3a (抗CD3单克隆抗体HIT3a的制备和特异性鉴定), Acta Academiae Medicinae Sinicae (中国医学科学院学报),1993, 15:157-162.[6] Xiong D S(熊冬生),Yang C Z(杨纯正),Shao X F(邵晓枫)et al. Generation
因为抗体的结合而减少;在人体血清中无游离的CD20存在;最重要的是B淋巴细胞瘤上的CD20少有内吞和脱落的发生[ 2-5 ] 。1997年,以CD20为靶点的嵌合抗CD20单克隆抗体Rituxan已获准应用于B细胞淋巴瘤的治疗[ 6 ]。HI47(IgG3)是我所于1990年研制成功的国内第一个抗CD20鼠源性单克窿抗体,第四届国际人类白细胞分化抗原会议将HI47命名为CD20+X[ 7 ] 。我们利用噬菌体显示技术从HI47杂交瘤细胞中克隆到抗CD20抗体HI47可变区基因,将该基因构建成为嵌合的抗
20B淋巴细胞表面的膜蛋白CD20对B淋巴细胞的增殖和分化具有调节作用[1]。由于CD20分子仅在前-B淋巴细胞、未成熟B淋巴细胞、成熟B淋巴细胞、激活B淋巴细胞中表达,而在浆细胞、淋巴多能干细胞以及其它组织均无CD20的表达[2,3,4],在人体血清中亦无游离CD20的存在[5],因此CD20可作为B淋巴细胞瘤治疗的一个理想治疗靶点。限制抗体临床使用的因素主要有抗体产生的免疫原性和抗体的生产能力是否能够满足临床需要。第四届国际人类白细胞分化抗原会议将鼠源性单克隆抗CD20抗体HI47(IgG3)正式命名为CD20+X
技术资料暂无技术资料 索取技术资料





